Functional genomics data
GlobusGenotyping of human cancer cell lines
Data files
Download
Too many files!
You can download upto 1000 files at a time. For downloading a higher number of files, please use our alternative downloading methods.
Linked Information
| Name | Section | Type |
|---|---|---|
| A-AFFY-107 | Array Designs | Array Design |
| A-AFFY-72 | Array Designs | Array Design |
Showing 1 to 2 of 2 entries
Links Extracted from Files
| Link | Type | File |
|---|
-
Richard Wooster
Richard Wooster
Email: richard.f.wooster@gsk.com
Phone: 610-270-6551
Role: submitter
AccessionE-MTAB-38
Study typegenotyping by array
OrganismHomo sapiens
DescriptionMultiple genome-wide microarray 500K SNP studies performed to measure the genotype profile of various cancer cell lines
Publication
None
Multiple genome-wide microarray 500K SNP studies performed to measure the genotype profile of various cancer cell lines
Protocols
show table
| Name | Type | Description | Software |
|---|---|---|---|
| P-AFFY-6 | feature_extraction | Title: Affymetrix CEL analysis. Description: | MicroArraySuite 5.0 |
| P-MTAB-1056 | grow | Cell Lines were plated and digested with restriction enzyme Sty or NSP | |
| P-MTAB-1057 | nucleic_acid_extraction | Digested DNA was ligated to an adaptor and amplified by PCR using Platinum Pfx DNA Polymerase, yeilding a product of 250-2000bp | |
| P-MTAB-1058 | labeling | Genechip DNA Labeling biotin-labeled reagent for end-labeling fragmented PCR amplicons - https://www.affymetrix.com/support/downloads/manuals/500k_assay_manual.pdf | |
| P-MTAB-1059 | hybridization | standard Affymetrix hybridization protocol - https://www.affymetrix.com/support/downloads/manuals/500k_assay_manual.pdf |
Samples
Sample count676
Experimental Designsdisease_state_design,
co-expression_design,
genotyping by array
Experimental FactorsCELLLINE,
BIOSOURCEPROVIDER,
CLINICALINFORMATION,
ORGANISMPART,
DISEASESTATE
Experimental Factors
Factors Table
show table
| ORGANISMPART | CLINICALINFORMATION | BIOSOURCEPROVIDER | CELLLINE | DISEASESTATE | No. of Samples |
|---|---|---|---|---|---|
| bladder | ICDO: C67 | ATCC | HT1197 | Carcinoma | 2 |
| bladder | ICDO: C67 | ATCC | UMUC3 | Carcinoma | 2 |
| bladder | ICDO: C67 | ATCC | SW780 | Carcinoma | 2 |
| bladder | ICDO: C67 | DSMZ | 639V | Carcinoma | 2 |
| bladder | ICDO: C67 | ATCC | SCaBER | Squamous Cell Carcinoma | 2 |
| bladder | ICDO: C67 | ATCC | 5637 | Carcinoma | 2 |
| bladder | ICDO: C67 | ATCC | HT1376 | Carcinoma | 2 |
| bladder | ICDO: C67 | ATCC | J82 | Carcinoma | 2 |
| bladder | ICDO: C67 | DSMZ | BFTC905 | Carcinoma | 2 |
| bladder | ICDO: C67 | DSMZ | 647V | Carcinoma | 2 |
| Bone | ICDO: C49 | ATCC | SW1353 | Sarcoma | 2 |
| Bone | ICDO: C40 | ATCC | MG63 | Osteosarcoma | 2 |
| Bone | ICDO: C49 | ATCC | RDES | Sarcoma | 2 |
| Bone | ICDO: C49 | ATCC | SJSA1 | Osteosarcoma | 2 |
| Brain | ICDO: C71 | ATCC | D341Med | Medulloblastoma | 2 |
| Brain | ICDO: C71 | ATCC | U138MG | glioma | 2 |
| Brain | ICDO: C71 | ATCC | NCIH295R | Carcinoma | 2 |
| Brain | ICDO: C72 | ATCC | BE2C | neuroblastoma | 2 |
| Brain | ICDO: C72 | ATCC | CHP212 | neuroblastoma | 2 |
| Brain | ICDO: C71 | ATCC | A172 | Brain Glioblastoma | 2 |
| Brain | ICDO: C72 | ATCC | SKNDZ | neuroblastoma | 2 |
| Central Nervous System | ICDO: C71 | ATCC | MCIXC | neuroblastoma | 2 |
| Central Nervous System | ICDO: C71 | ATCC | SW1783 | Glioblastoma | 2 |
| Central Nervous System | ICDO: C71 | DSMZ | DKMG | Glioblastoma | 2 |
| Central Nervous System | ICDO: C71 | DMSZ | SNB19 | Glioblastoma | 2 |
| Central Nervous System | ICDO: C71 | ATCC | SKNAS | neuroblastoma | 2 |
| Central Nervous System | ICDO: C71 | ATCC | H4 | Glioblastoma | 2 |
| Central Nervous System | ICDO: C71 | ATCC | D283Med | Medulloblastoma | 2 |
| Central Nervous System | ICDO: C71 | ATCC | CCFSTTG1 | Astrocytoma | 2 |
| Central Nervous System | ICDO: C71 | ATCC | SKNFI | neuroblastoma | 2 |
| Central Nervous System | ICDO: C71 | ATCC | DBTRG05MG | Glioblastoma | 2 |
| Central Nervous System | ICDO: C71 | ATCC | SW1088 | Glioblastoma | 2 |
| Cervix Uteri | ICDO: C53 | ATCC | DoTc2 | Carcinoma | 2 |
| Cervix Uteri | ICDO: C53 | ATCC | C4I | Carcinoma | 2 |
| Cervix Uteri | ICDO: C53 | ATCC | SiHa | Carcinoma | 2 |
| Cervix Uteri | ICDO: C53 | ATCC | HT3 | Carcinoma | 2 |
| Cervix Uteri | ICDO: C53 | ATCC | SW756 | Carcinoma | 2 |
| Cervix Uteri | ICDO: C53 | ATCC | C4II | Carcinoma | 2 |
| Cervix Uteri | ICDO: C53 | ATCC | C33A | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | WIDR | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | SW1116 | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | NCIH716 | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | NCIH747 | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | LS174T | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | T84 | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | HCT8 | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | HCT15 | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | COLO320HSR | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | LS1034 | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | SW837 | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | RKOE6 | Colon Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | SW48 | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | COLO201 | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | SW948 | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | SW1417 | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | SW480 | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | SW620 | Carcinoma | 2 |
| Colon | ICDO: C18 | ATCC | SW403 | Carcinoma | 2 |
| Connective and Soft Tissue | ICDO: C49 | ATCC | TE381T | rhabdomyosarcoma | 2 |
| Connective Tissue | ICDO: C49 | ATCC | SW684 | Fibrosarcoma | 2 |
| Connective Tissue | ICDO: C49 | ATCC | SW872 | Liposarcoma | 2 |
| Connective Tissue | ICDO: C49 | ATCC | HT1080 | Fibrosarcoma | 2 |
| Esophagus | ICDO: C15 | DSMZ | KYSE30 | Squamous Cell Carcinoma | 2 |
| Esophagus | ICDO: C15 | ECACC | OE19 | Esophageal Carcinoma | 2 |
| Esophagus | ICDO: C15 | ECACC | OE21 | Esophageal Carcinoma | 2 |
| Esophagus | ICDO: C15 | ECACC | OE33 | Esophageal Carcinoma | 2 |
| Eye | ICDO: C69 | ATCC | Y79 | Retinoblastoma | 2 |
| Eye | ICDO: C69 | ATCC | WERIRb1 | retinoblastoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | HDMYZ | Hodgkin Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | BC1 | B-Cell Neoplasm | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | HH | Cutaneous T Cell Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | ARH77 | Plasma Cell Myeloma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | EB3 | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | TO175T | haematopoietic | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | MOLT16 | Acute Lymphoblastic Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | CMLT1 | Blast Phase Chronic Myelogenous Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | MHHPREB1 | B-Cell Neoplasm | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | CESS | Acute Myeloid Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | HSSultan | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | K562 | Chronic Myelogenous Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | JRT3T35 | Acute Lymphoblastic Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | NALM1 | Blast Phase Chronic Myelogenous Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | HT | B-Cell Neoplasm | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | DOHH2 | B-Cell Neoplasm | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | MOLT3 | T-Cell Acute Lymphoblastic Leukemia (TALL) | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | RL | Non-Hodgkin Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | Jiyoye | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | EB2 | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | CEMC1 | Acute T Cell Lymphoblastic Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | SUDHL5 | Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | REC1 | B-Cell Neoplasm | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | MEG01 | Chronic Myelogenous Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | TANOUE | Acute Lymphoblastic Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | L428 | Hodgkin Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | RPMI6666 | Hodgkin Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | MOLT4 | Acute Lymphoblastic Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | BC3 | B-Cell Neoplasm | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | HEL9217 | Erythroleukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | Farage | Large B-cell lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DMSZ | HL60 | Acute Myeloid Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | EM2 | Blast Phase Chronic Myelogenous Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | RPMI8226 | Myeloma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | SUDHL10 | Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | HuT78 | Cutaneous T Cell Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C06 | ATCC | EB1 | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | DG75 | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | RCHACV | Precursor B-Lymphoblastic Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | Daudi | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | GDM1 | Acute Myeloid Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | CA46 | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | MJ | T-Cell Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | MEC1 | Chronic Lymphocytic Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | MC116 | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | P3HR1 | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | SKO007 | Myeloma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | NC37 | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | Toledo | Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | SUDHL16 | Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C48 | DSMZ | SUDHL6 | Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | MCCAR | Plasma Cell Myeloma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | NALM6 | Acute Lymphoblastic Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | CCRFCEM | Acute T Cell Lymphoblastic Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | CROAP2 | B-Cell Neoplasm | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | JVM3 | Acute B Cell Lymphocytic Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | Raji | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | JM1 | Acute Lymphoblastic Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | SR | Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | BDCM | Acute Myeloid Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | CCRFSB | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | PLB985 | Acute Myeloid Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | Pfeiffer | Large B-cell lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | CROAP5 | B-Cell Neoplasm | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | MV4II | Myeloid Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | KG1 | Acute Myeloid Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | BV173 | Blast Phase Chronic Myelogenous Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | 1A2 | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | Kasumi2 | Acute B Cell Lymphocytic Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | ST486 | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | HuNS1 | Myeloma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | THP1 | Acute Myeloid Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | HL60MX1 | AML | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | U266B1 | Myeloma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | GA10 | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | KU812 | Chronic Myelogenous Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | ML2 | Acute Myeloid Leukemia | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | DB | B-Cell Neoplasm | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | NAMALWA | Burkitt Lymphoma | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | ATCC | BC2 | B-Cell Neoplasm | 2 |
| Hematopoietic and Lymphatic System | ICDO: C42 | DSMZ | SEM | Precursor B-Lymphoblastic Leukemia | 2 |
| kidney | ICDO: C64 | ATCC | Caki1 | Carcinoma | 2 |
| kidney | ICDO: C64 | ATCC | A498 | Carcinoma | 2 |
| kidney | ICDO: C64 | ATCC | Caki2 | Choriocarcinoma | 2 |
| kidney | ICDO: C64 | DSMZ | CAL54 | Carcinoma | 2 |
| kidney | ICDO: C64 | ATCC | G401 | Wilms Tumor | 2 |
| kidney | ICDO: C64 | ATCC | SKNEP1 | Wilms tumour | 2 |
| kidney | ICDO: C64 | ATCC | G402 | Leiomyoblastoma | 2 |
| kidney | ICDO: C64 | ATCC | ACHN | Carcinoma | 2 |
| kidney | ICDO: C64 | ATCC | 769P | Carcinoma | 2 |
| Liver | ICDO: C22 | ATCC | C3A | Carcinoma | 2 |
| Liver | ICDO: C22 | ATCC | HepG2 | Carcinoma | 2 |
| Liver | ICDO: C22 | ATCC | SNU182 | Carcinoma | 2 |
| Liver | ICDO: C22 | ATCC | SNU398 | Carcinoma | 2 |
| Liver | ICDO: C22 | ATCC | SNU387 | Carcinoma | 2 |
| Liver | ICDO: C22 | ATCC | SNU449 | Carcinoma | 2 |
| Liver | ICDO: C22 | ATCC | SNU423 | Carcinoma | 2 |
| Liver | ICDO: C22 | ATCC | Hep3B | Hepatocellular Carcinoma | 2 |
| Liver | ICDO: C22 | ATCC | SNU475 | Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1930 | Small Cell Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | DMS53 | Small Cell Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1623 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1436 | Small Cell Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | DMS79 | Small Cell Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH596 | carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH2170 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1703 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH526 | carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH720 | Lung Atypical Carcinoid Tumor | 2 |
| lung | ICDO: C34 | ATCC | NCIH441 | Papillary Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH650 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | DMS114 | Small Cell Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | Calu3 | carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH69 | Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1404 | unavailable | 2 |
| lung | ICDO: C34 | ATCC | SHP77 | Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1573 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH2171 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH23 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | SW900 | Small Cell Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | Calu6 | Anaplastic Carcinoma | 2 |
| lung | ICDO: C34 | ECACC | CORL88 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH187 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1048 | Myeloid Leukemia | 2 |
| lung | ICDO: C34 | ATCC | NCIH1355 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1770 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH2009 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1993 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH322 | Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1092 | Small Cell Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1651 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH446 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH2052 | Mesothelioma | 2 |
| lung | ICDO: C34 | ATCC | NCIH2087 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1650 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ECACC | DMS273 | Small Cell Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH838 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | SW1573 | Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH226 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | DMS153 | Small Cell Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH522 | Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1395 | Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1437 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1755 | carcinoma (NSCL) | 2 |
| lung | ICDO: C34 | ATCC | A427 | Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | WI38 | normal | 2 |
| lung | ICDO: C34 | ATCC | NCIH2030 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1792 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH2228 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1155 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH661 | Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH524 | Small Cell Lung Carcinoma | 2 |
| lung | ICDO: C34 | ECACC | CORL279 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1581 | Large Cell Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1975 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH378 | carcinoma | 2 |
| lung | ICDO: C34 | ECACC | CORL23 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH2081 | Small Cell Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH748 | Small Cell Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH82 | Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH2122 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH2195 | Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | H69AR | Small Cell carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH2126 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1838 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1666 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH358 | Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH209 | carcinoma | 2 |
| lung | ICDO: C34 | ATCC | Calu1 | Squamous Cell Carcinoma | 2 |
| lung | ICDO: C49 | ATCC | GCT | Sarcoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1793 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1618 | Small Cell Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH2107 | Small Cell Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH520 | carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH1694 | Small Cell Lung Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH146 | carcinoma | 2 |
| lung | ICDO: C34 | ECACC | CORL105 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH2347 | Lung Adenocarcinoma | 2 |
| lung | ICDO: C34 | ATCC | SKMES1 | Squamous Cell Carcinoma | 2 |
| lung | ICDO: C34 | ATCC | NCIH810 | Lung Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | HCC1395 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | BT20 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | HCC38 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | MDAMB175VII | Carcinoma | 2 |
| mammary gland | ICDO: C50 | DSMZ | DU4475 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | UACC893 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | DSMZ | KPL1 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | HCC1008 | unavailable | 2 |
| mammary gland | ICDO: C50 | ATCC | MDAMB453 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | HCC1143 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | HCC1937 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | UACC812 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | HCC1954 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | HCC70 | carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | HCC1599 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | HCC2218 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | DSMZ | EFM19 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | MCF7 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | BT474 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | DSMZ | MT3 | Carcinoma | 2 |
| mammary gland | ICDO: C50 | ATCC | HCC2157 | Carcinoma | 2 |
| muscle | ICDO: C49 | ATCC | RD | Osteosarcoma | 2 |
| muscle | ICDO: C49 | ATCC | SJRH30 | Rhabdomyosarcoma | 2 |
| muscle | ICDO: C49 | ATCC | A673 | Rhabdomyosarcoma | 2 |
| muscle | ICDO: C49 | ATCC | A204 | Rhabdomyosarcoma | 2 |
| Ovary | ICDO: C56 | ATCC | Caov4 | carcinoma | 2 |
| Ovary | ICDO: C56 | ATCC | ES2 | Clear Cell Adenocarcinoma | 2 |
| Ovary | ICDO: C56 | ATCC | CaOv3 | Carcinoma | 2 |
| Ovary | ICDO: C56 | ATCC | SKOV3 | Carcinoma | 2 |
| Ovary | ICDO: C56 | DSMZ | COLO704 | Adenocarcinoma | 2 |
| Ovary | ICDO: C56 | ATCC | OV90 | Ovarian Serous Adenocarcinoma | 2 |
| Ovary | ICDO: C56 | ATCC | OVCAR3 | carcinoma | 2 |
| Pancreas | ICDO: C25 | ATCC | HPAFII | Carcinoma | 2 |
| Pancreas | ICDO: C25 | ATCC | HPAC | Adenocarcinoma | 2 |
| Pancreas | ICDO: C25 | ECACC | HuPT4 | Carcinoma | 2 |
| Pancreas | ICDO: C25 | ATCC | MIA Paca-2 | Carcinoma | 2 |
| Pancreas | ICDO: C25 | ATCC | Capan1 | Carcinoma | 2 |
| Pancreas | ICDO: C25 | DSMZ | YPAC | Carcinoma | 2 |
| Pancreas | ICDO: C25 | ATCC | SW1990 | Carcinoma | 2 |
| Pancreas | ICDO: C25 | ATCC | Capan2 | Adenocarcinoma | 2 |
| Pancreas | ICDO: C25 | ATCC | AsPC1 | Carcinoma | 2 |
| Pharynx | ICDO: C13 | ATCC | Detroit562 | Carcinoma | 2 |
| Pharynx | ICDO: C13 | ATCC | FaDu | Carcinoma | 2 |
| Placenta | ICDO: C58 | ATCC | JEG3 | Choriocarcinoma | 2 |
| Placenta | ICDO: C58 | ATCC | JAR | Choriocarcinoma | 2 |
| Placenta | ICDO: C58 | ATCC | BeWo | Choriocarcinoma | 2 |
| prostate | ICDO: C61 | ATCC | CaHPV10 | Adenocarcinoma | 2 |
| prostate | ICDO: C61 | DMSZ | BM1604 | Carcinoma | 2 |
| prostate | ICDO: C61 | ATCC | RWPE1 | Carcinoma | 2 |
| prostate | ICDO: C61 | ATCC | 22Rv1 | Carcinoma | 2 |
| prostate | ICDO: C61 | DSMZ | BPH1 | hyperplasia | 2 |
| prostate | ICDO: C61 | ATCC | NCIH660 | unavailable | 2 |
| Rectum | ICDO: C20 | ATCC | SW1463 | Carcinoma | 2 |
| Rectum | ICDO: C20 | ATCC | NCIH630 | Melanoma | 2 |
| Sarcoma | ICDO: C49 | ATCC | KHOS240S | Osteosarcoma | 2 |
| Sarcoma | ICDO: C49 | ATCC | HOS | Osteosarcoma | 2 |
| Skin | ICDO: C44 | ATCC | C32TG | Amelanotic Skin Melanoma | 2 |
| Skin | ICDO: C44 | ATCC | A7 | Melanoma | 2 |
| Skin | ICDO: C44 | ATCC | SH4 | Melanoma | 2 |
| Skin | ICDO: C44 | ATCC | WM115 | Melanoma | 2 |
| Skin | ICDO: C44 | ATCC | CHL1 | Melanoma | 2 |
| Skin | ICDO: C44 | ATCC | SKMEL1 | Melanoma | 2 |
| Skin | ICDO: C44 | ATCC | Malme3M | Melanoma | 2 |
| Skin | ICDO: C44 | ATCC | COLO829 | Melanoma | 2 |
| Skin | ICDO: C44 | ATCC | A375 | Melanoma | 2 |
| Skin | ICDO: C44 | ATCC | HMCB | Melanoma | 2 |
| Skin | ICDO: C44 | ATCC | SKMEL3 | Melanoma | 2 |
| Skin | ICDO: C44 | ATCC | A101D | Melanoma | 2 |
| Stomach | ICDO: C16 | ATCC | SNU16 | Carcinoma | 2 |
| Stomach | ICDO: C16 | ATCC | SNU1 | Carcinoma | 2 |
| Stomach | ICDO: C16 | ATCC | KATOIII | Carcinoma | 2 |
| Stomach | ICDO: C16 | ATCC | SNU5 | Carcinoma | 2 |
| Stomach | ICDO: C16 | ATCC | AGS | Carcinoma | 2 |
| Synovial Membrane | ICDO: C49 | ATCC | SW982 | Synovial Sarcoma | 2 |
| Thyroid gland | ICDO: C73 | ATCC | TT | Carcinoma | 2 |
| Thyroid gland | ICDO: C73 | DSMZ | CAL62 | Carcinoma | 2 |
| Thyroid gland | ICDO: C73 | DSMZ | CGTHW1 | Carcinoma | 2 |
| Thyroid gland | ICDO: C73 | DSMZ | BHT101 | Carcinoma | 2 |
| Uterus | ICDO: C55 | ATCC | KLE | Carcinoma | 2 |
| Uterus | ICDO: C49 | ATCC | SKUT1 | Leiomyosarcoma | 2 |
| Uterus | ICDO: C55 | ATCC | AN3CA | Carcinoma | 2 |
| Uterus | ICDO: C49 | ATCC | MESSA | Sarcoma | 2 |
| Uterus | ICDO: C55 | ATCC | HEC1A | Carcinoma | 2 |
| Uterus | ICDO: C49 | ATCC | MESSAMX2 | Uterine | 2 |
| Uterus | ICDO: C55 | ATCC | RL952 | Carcinoma | 2 |
| Uterus | ICDO: C49 | ATCC | MESSADX5 | sarcoma | 2 |
| Uterus | ICDO: C55 | ATCC | HEC1B | Carcinoma | 2 |
| Vulva | ICDO: C49 | ATCC | SKLMS1 | Sarcoma | 2 |
| Vulva | ICDO: C51 | ATCC | SW954 | Carcinoma | 2 |
| Vulva | ICDO: C51 | ATCC | SW962 | Carcinoma | 2 |
OrganismpartOvary,
lung,
muscle,
Central Nervous System,
Stomach,
Pharynx,
Uterus,
Vulva,
prostate,
Hematopoietic and Lymphatic System,
kidney,
Pancreas,
Connective and Soft Tissue,
Brain,
Skin,
... 14 other values
ClinicalinformationICDO: C20,
ICDO: C16,
ICDO: C67,
ICDO: C25,
ICDO: C18,
ICDO: C49,
ICDO: C40,
ICDO: C73,
ICDO: C48,
ICDO: C06,
ICDO: C64,
ICDO: C71,
ICDO: C53,
ICDO: C13,
ICDO: C50,
... 12 other values
BiosourceproviderDSMZ,
DMSZ,
ATCC,
ECACC
CelllineSW1417,
HOS,
L428,
NCIH295R,
AsPC1,
Caov4,
NCIH526,
JVM3,
A673,
SW982,
RPMI8226,
SNU1,
OE33,
REC1,
Capan2,
... 323 other values
DiseasestateAcute Myeloid Leukemia,
Mesothelioma,
Liposarcoma,
Small Cell carcinoma,
Medulloblastoma,
Chronic Myelogenous Leukemia,
Myeloma,
Chronic Lymphocytic Leukemia,
Astrocytoma,
Acute T Cell Lymphoblastic Leukemia,
B-Cell Neoplasm,
Small Cell Carcinoma,
Melanoma,
Large Cell Lung Carcinoma,
Lung Adenocarcinoma,
... 55 other values
Source Characteristics
Characteristics Table
show table
| ClinicalInformation | OrganismPart | CellLine | BioSourceProvider | DiseaseState | No. of Samples |
|---|---|---|---|---|---|
| C06 | Hematopoietic and Lymphatic System | EB1 | ATCC | Burkitt Lymphoma | 2 |
| C13 | Pharynx | Detroit562 | ATCC | Carcinoma | 2 |
| C13 | Pharynx | FaDu | ATCC | Carcinoma | 2 |
| C15 | Esophagus | KYSE30 | DSMZ | Squamous Cell Carcinoma | 2 |
| C15 | Esophagus | OE19 | ECACC | Esophageal Carcinoma | 2 |
| C15 | Esophagus | OE21 | ECACC | Esophageal Carcinoma | 2 |
| C15 | Esophagus | OE33 | ECACC | Esophageal Carcinoma | 2 |
| C16 | Stomach | SNU16 | ATCC | Carcinoma | 2 |
| C16 | Stomach | SNU1 | ATCC | Carcinoma | 2 |
| C16 | Stomach | KATOIII | ATCC | Carcinoma | 2 |
| C16 | Stomach | SNU5 | ATCC | Carcinoma | 2 |
| C16 | Stomach | AGS | ATCC | Carcinoma | 2 |
| C18 | Colon | WIDR | ATCC | Carcinoma | 2 |
| C18 | Colon | SW1116 | ATCC | Carcinoma | 2 |
| C18 | Colon | NCIH716 | ATCC | Carcinoma | 2 |
| C18 | Colon | NCIH747 | ATCC | Carcinoma | 2 |
| C18 | Colon | LS174T | ATCC | Carcinoma | 2 |
| C18 | Colon | T84 | ATCC | Carcinoma | 2 |
| C18 | Colon | HCT8 | ATCC | Carcinoma | 2 |
| C18 | Colon | HCT15 | ATCC | Carcinoma | 2 |
| C18 | Colon | COLO320HSR | ATCC | Carcinoma | 2 |
| C18 | Colon | LS1034 | ATCC | Carcinoma | 2 |
| C18 | Colon | SW837 | ATCC | Carcinoma | 2 |
| C18 | Colon | RKOE6 | ATCC | Colon Carcinoma | 2 |
| C18 | Colon | SW48 | ATCC | Carcinoma | 2 |
| C18 | Colon | COLO201 | ATCC | Carcinoma | 2 |
| C18 | Colon | SW948 | ATCC | Carcinoma | 2 |
| C18 | Colon | SW1417 | ATCC | Carcinoma | 2 |
| C18 | Colon | SW480 | ATCC | Carcinoma | 2 |
| C18 | Colon | SW620 | ATCC | Carcinoma | 2 |
| C18 | Colon | SW403 | ATCC | Carcinoma | 2 |
| C20 | Rectum | SW1463 | ATCC | Carcinoma | 2 |
| C20 | Rectum | NCIH630 | ATCC | Melanoma | 2 |
| C22 | Liver | C3A | ATCC | Carcinoma | 2 |
| C22 | Liver | HepG2 | ATCC | Carcinoma | 2 |
| C22 | Liver | SNU182 | ATCC | Carcinoma | 2 |
| C22 | Liver | SNU398 | ATCC | Carcinoma | 2 |
| C22 | Liver | SNU387 | ATCC | Carcinoma | 2 |
| C22 | Liver | SNU449 | ATCC | Carcinoma | 2 |
| C22 | Liver | SNU423 | ATCC | Carcinoma | 2 |
| C22 | Liver | Hep3B | ATCC | Hepatocellular Carcinoma | 2 |
| C22 | Liver | SNU475 | ATCC | Carcinoma | 2 |
| C25 | Pancreas | HPAFII | ATCC | Carcinoma | 2 |
| C25 | Pancreas | HPAC | ATCC | Adenocarcinoma | 2 |
| C25 | Pancreas | HuPT4 | ECACC | Carcinoma | 2 |
| C25 | Pancreas | MIA Paca-2 | ATCC | Carcinoma | 2 |
| C25 | Pancreas | Capan1 | ATCC | Carcinoma | 2 |
| C25 | Pancreas | YPAC | DSMZ | Carcinoma | 2 |
| C25 | Pancreas | SW1990 | ATCC | Carcinoma | 2 |
| C25 | Pancreas | Capan2 | ATCC | Adenocarcinoma | 2 |
| C25 | Pancreas | AsPC1 | ATCC | Carcinoma | 2 |
| C34 | lung | NCIH1930 | ATCC | Small Cell Lung Carcinoma | 2 |
| C34 | lung | DMS53 | ATCC | Small Cell Lung Carcinoma | 2 |
| C34 | lung | NCIH1623 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH1436 | ATCC | Small Cell Lung Carcinoma | 2 |
| C34 | lung | DMS79 | ATCC | Small Cell Carcinoma | 2 |
| C34 | lung | NCIH596 | ATCC | Carcinoma | 2 |
| C34 | lung | NCIH2170 | ATCC | Lung Carcinoma | 2 |
| C34 | lung | NCIH1703 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH526 | ATCC | Carcinoma | 2 |
| C34 | lung | NCIH720 | ATCC | Lung Atypical Carcinoid Tumor | 2 |
| C34 | lung | NCIH441 | ATCC | Papillary Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH650 | ATCC | Lung Carcinoma | 2 |
| C34 | lung | DMS114 | ATCC | Small Cell Lung Carcinoma | 2 |
| C34 | lung | Calu3 | ATCC | Carcinoma | 2 |
| C34 | lung | NCIH69 | ATCC | Carcinoma | 2 |
| C34 | lung | NCIH1404 | ATCC | Adenocarcinoma | 2 |
| C34 | lung | SHP77 | ATCC | Carcinoma | 2 |
| C34 | lung | NCIH1573 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH2171 | ATCC | Lung Carcinoma | 2 |
| C34 | lung | NCIH23 | ATCC | Lung Carcinoma | 2 |
| C34 | lung | SW900 | ATCC | Small Cell Carcinoma | 2 |
| C34 | lung | Calu6 | ATCC | Anaplastic Carcinoma | 2 |
| C34 | lung | CORL88 | ECACC | Lung Carcinoma | 2 |
| C34 | lung | NCIH187 | ATCC | Lung Carcinoma | 2 |
| C34 | lung | NCIH1048 | ATCC | Myeloid Leukemia | 2 |
| C34 | lung | NCIH1355 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH1770 | ATCC | Lung Carcinoma | 2 |
| C34 | lung | NCIH2009 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH1993 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH322 | ATCC | Carcinoma | 2 |
| C34 | lung | NCIH1092 | ATCC | Small Cell Lung Carcinoma | 2 |
| C34 | lung | NCIH1651 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH446 | ATCC | Lung Carcinoma | 2 |
| C34 | lung | NCIH2052 | ATCC | Mesothelioma | 2 |
| C34 | lung | NCIH2087 | ATCC | Lung Carcinoma | 2 |
| C34 | lung | NCIH1650 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | DMS273 | ECACC | Small Cell Lung Carcinoma | 2 |
| C34 | lung | NCIH838 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | SW1573 | ATCC | Carcinoma | 2 |
| C34 | lung | NCIH226 | ATCC | Lung Carcinoma | 2 |
| C34 | lung | DMS153 | ATCC | Small Cell Lung Carcinoma | 2 |
| C34 | lung | NCIH522 | ATCC | Carcinoma | 2 |
| C34 | lung | NCIH1395 | ATCC | Carcinoma | 2 |
| C34 | lung | NCIH1437 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH1755 | ATCC | Adenocarcinoma | 2 |
| C34 | lung | A427 | ATCC | Carcinoma | 2 |
| C34 | lung | WI38 | ATCC | normal | 2 |
| C34 | lung | NCIH2030 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH1792 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH2228 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH1155 | ATCC | Lung Carcinoma | 2 |
| C34 | lung | NCIH661 | ATCC | Carcinoma | 2 |
| C34 | lung | NCIH524 | ATCC | Small Cell Lung Carcinoma | 2 |
| C34 | lung | CORL279 | ECACC | Lung Carcinoma | 2 |
| C34 | lung | NCIH1581 | ATCC | Large Cell Lung Carcinoma | 2 |
| C34 | lung | NCIH1975 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH378 | ATCC | Carcinoma | 2 |
| C34 | lung | CORL23 | ECACC | Lung Carcinoma | 2 |
| C34 | lung | NCIH2081 | ATCC | Small Cell Lung Carcinoma | 2 |
| C34 | lung | NCIH748 | ATCC | Small Cell Lung Carcinoma | 2 |
| C34 | lung | NCIH82 | ATCC | Carcinoma | 2 |
| C34 | lung | NCIH2122 | ATCC | Lung Carcinoma | 2 |
| C34 | lung | NCIH2195 | ATCC | Lung Carcinoma | 2 |
| C34 | lung | H69AR | ATCC | Small Cell Lung Carcinoma | 2 |
| C34 | lung | NCIH2126 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH1838 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH1666 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH358 | ATCC | Carcinoma | 2 |
| C34 | lung | NCIH209 | ATCC | Lung Carcinoma | 2 |
| C34 | lung | Calu1 | ATCC | Squamous Cell Carcinoma | 2 |
| C34 | lung | NCIH1793 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH1618 | ATCC | Small Cell Lung Carcinoma | 2 |
| C34 | lung | NCIH2107 | ATCC | Small Cell Lung Carcinoma | 2 |
| C34 | lung | NCIH520 | ATCC | Carcinoma | 2 |
| C34 | lung | NCIH1694 | ATCC | Small Cell Lung Carcinoma | 2 |
| C34 | lung | NCIH146 | ATCC | Carcinoma | 2 |
| C34 | lung | CORL105 | ECACC | Lung Adenocarcinoma | 2 |
| C34 | lung | NCIH2347 | ATCC | Lung Adenocarcinoma | 2 |
| C34 | lung | SKMES1 | ATCC | Squamous Cell Carcinoma | 2 |
| C34 | lung | NCIH810 | ATCC | Lung Carcinoma | 2 |
| C40 | Bone | MG63 | ATCC | Osteosarcoma | 2 |
| C42 | Hematopoietic and Lymphatic System | HDMYZ | DSMZ | Hodgkin Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | BC1 | ATCC | B-Cell Neoplasm | 2 |
| C42 | Hematopoietic and Lymphatic System | HH | ATCC | Cutaneous T Cell Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | ARH77 | ATCC | Plasma Cell Myeloma | 2 |
| C42 | Hematopoietic and Lymphatic System | EB3 | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | TO175T | ATCC | Hodgkin Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | MOLT16 | DSMZ | Acute Lymphoblastic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | CMLT1 | DSMZ | Blast Phase Chronic Myelogenous Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | MHHPREB1 | DSMZ | B-Cell Neoplasm | 2 |
| C42 | Hematopoietic and Lymphatic System | CESS | ATCC | Acute Myeloid Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | HSSultan | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | K562 | ATCC | Chronic Myelogenous Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | JRT3T35 | ATCC | Acute Lymphoblastic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | NALM1 | DSMZ | Blast Phase Chronic Myelogenous Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | HT | ATCC | B-Cell Neoplasm | 2 |
| C42 | Hematopoietic and Lymphatic System | DOHH2 | DSMZ | B-Cell Neoplasm | 2 |
| C42 | Hematopoietic and Lymphatic System | MOLT3 | ATCC | Acute T Cell Lymphoblastic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | RL | ATCC | Non-Hodgkin Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | Jiyoye | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | EB2 | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | CEMC1 | ATCC | Acute T Cell Lymphoblastic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | SUDHL5 | DSMZ | Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | REC1 | DSMZ | B-Cell Neoplasm | 2 |
| C42 | Hematopoietic and Lymphatic System | MEG01 | ATCC | Chronic Myelogenous Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | TANOUE | DSMZ | Acute Lymphoblastic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | L428 | DSMZ | Hodgkin Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | RPMI6666 | ATCC | Hodgkin Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | MOLT4 | ATCC | Acute Lymphoblastic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | BC3 | ATCC | B-Cell Neoplasm | 2 |
| C42 | Hematopoietic and Lymphatic System | HEL9217 | ATCC | Erythroleukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | Farage | ATCC | Precursor B-Lymphoblastic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | HL60 | DMSZ | Acute Myeloid Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | EM2 | DSMZ | Blast Phase Chronic Myelogenous Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | RPMI8226 | ATCC | Myeloma | 2 |
| C42 | Hematopoietic and Lymphatic System | SUDHL10 | DSMZ | Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | HuT78 | ATCC | Cutaneous T Cell Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | DG75 | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | RCHACV | DSMZ | Precursor B-Lymphoblastic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | Daudi | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | GDM1 | DSMZ | Acute Myeloid Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | CA46 | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | MJ | ATCC | T-Cell Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | MEC1 | DSMZ | Chronic Lymphocytic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | MC116 | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | P3HR1 | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | SKO007 | ATCC | Myeloma | 2 |
| C42 | Hematopoietic and Lymphatic System | NC37 | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | Toledo | ATCC | Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | SUDHL16 | DSMZ | Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | MCCAR | ATCC | Plasma Cell Myeloma | 2 |
| C42 | Hematopoietic and Lymphatic System | NALM6 | DSMZ | Acute Lymphoblastic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | CCRFCEM | ATCC | Acute T Cell Lymphoblastic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | CROAP2 | DSMZ | B-Cell Neoplasm | 2 |
| C42 | Hematopoietic and Lymphatic System | JVM3 | DSMZ | Acute B Cell Lymphocytic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | Raji | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | JM1 | ATCC | Acute Lymphoblastic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | SR | ATCC | Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | BDCM | ATCC | Acute Myeloid Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | CCRFSB | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | PLB985 | DSMZ | Acute Myeloid Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | Pfeiffer | ATCC | Precursor B-Lymphoblastic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | CROAP5 | DSMZ | B-Cell Neoplasm | 2 |
| C42 | Hematopoietic and Lymphatic System | MV4II | ATCC | Myeloid Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | KG1 | ATCC | Acute Myeloid Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | BV173 | DSMZ | Blast Phase Chronic Myelogenous Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | 1A2 | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | Kasumi2 | DSMZ | Acute B Cell Lymphocytic Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | ST486 | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | HuNS1 | ATCC | Myeloma | 2 |
| C42 | Hematopoietic and Lymphatic System | THP1 | ATCC | Acute Myeloid Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | HL60MX1 | ATCC | Acute Myeloid Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | U266B1 | ATCC | Myeloma | 2 |
| C42 | Hematopoietic and Lymphatic System | GA10 | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | KU812 | DSMZ | Chronic Myelogenous Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | ML2 | DSMZ | Acute Myeloid Leukemia | 2 |
| C42 | Hematopoietic and Lymphatic System | DB | ATCC | B-Cell Neoplasm | 2 |
| C42 | Hematopoietic and Lymphatic System | NAMALWA | ATCC | Burkitt Lymphoma | 2 |
| C42 | Hematopoietic and Lymphatic System | BC2 | ATCC | B-Cell Neoplasm | 2 |
| C42 | Hematopoietic and Lymphatic System | SEM | DSMZ | Precursor B-Lymphoblastic Leukemia | 2 |
| C44 | Skin | C32TG | ATCC | Amelanotic Skin Melanoma | 2 |
| C44 | Skin | A7 | ATCC | Melanoma | 2 |
| C44 | Skin | SH4 | ATCC | Melanoma | 2 |
| C44 | Skin | WM115 | ATCC | Melanoma | 2 |
| C44 | Skin | CHL1 | ATCC | Melanoma | 2 |
| C44 | Skin | SKMEL1 | ATCC | Melanoma | 2 |
| C44 | Skin | Malme3M | ATCC | Melanoma | 2 |
| C44 | Skin | COLO829 | ATCC | Melanoma | 2 |
| C44 | Skin | A375 | ATCC | Melanoma | 2 |
| C44 | Skin | HMCB | ATCC | Melanoma | 2 |
| C44 | Skin | SKMEL3 | ATCC | Melanoma | 2 |
| C44 | Skin | A101D | ATCC | Melanoma | 2 |
| C48 | Hematopoietic and Lymphatic System | SUDHL6 | DSMZ | Lymphoma | 2 |
| C49 | Connective and Soft Tissue | TE381T | ATCC | Rhabdomyosarcoma | 2 |
| C49 | Sarcoma | KHOS240S | ATCC | Osteosarcoma | 2 |
| C49 | muscle | RD | ATCC | Osteosarcoma | 2 |
| C49 | Bone | SW1353 | ATCC | Sarcoma | 2 |
| C49 | Connective Tissue | SW684 | ATCC | Fibrosarcoma | 2 |
| C49 | Uterus | SKUT1 | ATCC | Leiomyosarcoma | 2 |
| C49 | Vulva | SKLMS1 | ATCC | Sarcoma | 2 |
| C49 | Bone | RDES | ATCC | Sarcoma | 2 |
| C49 | Bone | SJSA1 | ATCC | Osteosarcoma | 2 |
| C49 | Connective Tissue | SW872 | ATCC | Liposarcoma | 2 |
| C49 | muscle | SJRH30 | ATCC | Rhabdomyosarcoma | 2 |
| C49 | Uterus | MESSA | ATCC | Sarcoma | 2 |
| C49 | Connective Tissue | HT1080 | ATCC | Fibrosarcoma | 2 |
| C49 | muscle | A673 | ATCC | Rhabdomyosarcoma | 2 |
| C49 | Uterus | MESSAMX2 | ATCC | Sarcoma | 2 |
| C49 | lung | GCT | ATCC | Sarcoma | 2 |
| C49 | Synovial Membrane | SW982 | ATCC | Synovial Sarcoma | 2 |
| C49 | Uterus | MESSADX5 | ATCC | Sarcoma | 2 |
| C49 | Sarcoma | HOS | ATCC | Osteosarcoma | 2 |
| C49 | muscle | A204 | ATCC | Rhabdomyosarcoma | 2 |
| C50 | mammary gland | HCC1395 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | BT20 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | HCC38 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | MDAMB175VII | ATCC | Carcinoma | 2 |
| C50 | mammary gland | DU4475 | DSMZ | Carcinoma | 2 |
| C50 | mammary gland | UACC893 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | KPL1 | DSMZ | Carcinoma | 2 |
| C50 | mammary gland | HCC1008 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | MDAMB453 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | HCC1143 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | HCC1937 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | UACC812 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | HCC1954 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | HCC70 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | HCC1599 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | HCC2218 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | EFM19 | DSMZ | Carcinoma | 2 |
| C50 | mammary gland | MCF7 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | BT474 | ATCC | Carcinoma | 2 |
| C50 | mammary gland | MT3 | DSMZ | Carcinoma | 2 |
| C50 | mammary gland | HCC2157 | ATCC | Carcinoma | 2 |
| C51 | Vulva | SW954 | ATCC | Carcinoma | 2 |
| C51 | Vulva | SW962 | ATCC | Carcinoma | 2 |
| C53 | Cervix Uteri | DoTc2 | ATCC | Carcinoma | 2 |
| C53 | Cervix Uteri | C4I | ATCC | Carcinoma | 2 |
| C53 | Cervix Uteri | SiHa | ATCC | Carcinoma | 2 |
| C53 | Cervix Uteri | HT3 | ATCC | Carcinoma | 2 |
| C53 | Cervix Uteri | SW756 | ATCC | Carcinoma | 2 |
| C53 | Cervix Uteri | C4II | ATCC | Carcinoma | 2 |
| C53 | Cervix Uteri | C33A | ATCC | Carcinoma | 2 |
| C55 | Uterus | KLE | ATCC | Carcinoma | 2 |
| C55 | Uterus | AN3CA | ATCC | Carcinoma | 2 |
| C55 | Uterus | HEC1A | ATCC | Carcinoma | 2 |
| C55 | Uterus | RL952 | ATCC | Carcinoma | 2 |
| C55 | Uterus | HEC1B | ATCC | Carcinoma | 2 |
| C56 | Ovary | Caov4 | ATCC | Carcinoma | 2 |
| C56 | Ovary | ES2 | ATCC | Clear Cell Adenocarcinoma | 2 |
| C56 | Ovary | CaOv3 | ATCC | Carcinoma | 2 |
| C56 | Ovary | SKOV3 | ATCC | Carcinoma | 2 |
| C56 | Ovary | COLO704 | DSMZ | Adenocarcinoma | 2 |
| C56 | Ovary | OV90 | ATCC | Ovarian Serous Adenocarcinoma | 2 |
| C56 | Ovary | OVCAR3 | ATCC | Carcinoma | 2 |
| C58 | Placenta | JEG3 | ATCC | Choriocarcinoma | 2 |
| C58 | Placenta | JAR | ATCC | Choriocarcinoma | 2 |
| C58 | Placenta | BeWo | ATCC | Choriocarcinoma | 2 |
| C61 | prostate | CaHPV10 | ATCC | Adenocarcinoma | 2 |
| C61 | prostate | BM1604 | DMSZ | Carcinoma | 2 |
| C61 | prostate | RWPE1 | ATCC | Carcinoma | 2 |
| C61 | prostate | 22Rv1 | ATCC | Carcinoma | 2 |
| C61 | prostate | BPH1 | DSMZ | Hyperplasia | 2 |
| C61 | prostate | NCIH660 | ATCC | Carcinoma | 2 |
| C64 | kidney | Caki1 | ATCC | Carcinoma | 2 |
| C64 | kidney | A498 | ATCC | Carcinoma | 2 |
| C64 | kidney | Caki2 | ATCC | Choriocarcinoma | 2 |
| C64 | kidney | CAL54 | DSMZ | Carcinoma | 2 |
| C64 | kidney | G401 | ATCC | Wilms Tumor | 2 |
| C64 | kidney | SKNEP1 | ATCC | Wilms tumour | 2 |
| C64 | kidney | G402 | ATCC | Leiomyoblastoma | 2 |
| C64 | kidney | ACHN | ATCC | Carcinoma | 2 |
| C64 | kidney | 769P | ATCC | Carcinoma | 2 |
| C67 | bladder | HT1197 | ATCC | Carcinoma | 2 |
| C67 | bladder | UMUC3 | ATCC | Carcinoma | 2 |
| C67 | bladder | SW780 | ATCC | Carcinoma | 2 |
| C67 | bladder | 639V | DSMZ | Carcinoma | 2 |
| C67 | bladder | SCaBER | ATCC | Squamous Cell Carcinoma | 2 |
| C67 | bladder | 5637 | ATCC | Carcinoma | 2 |
| C67 | bladder | HT1376 | ATCC | Carcinoma | 2 |
| C67 | bladder | J82 | ATCC | Carcinoma | 2 |
| C67 | bladder | BFTC905 | DSMZ | Carcinoma | 2 |
| C67 | bladder | 647V | DSMZ | Carcinoma | 2 |
| C69 | Eye | Y79 | ATCC | Retinoblastoma | 2 |
| C69 | Eye | WERIRb1 | ATCC | Retinoblastoma | 2 |
| C71 | Brain | D341Med | ATCC | Medulloblastoma | 2 |
| C71 | Central Nervous System | MCIXC | ATCC | neuroblastoma | 2 |
| C71 | Central Nervous System | SW1783 | ATCC | Glioblastoma | 2 |
| C71 | Brain | U138MG | ATCC | Glioblastoma | 2 |
| C71 | Central Nervous System | DKMG | DSMZ | Glioblastoma | 2 |
| C71 | Brain | NCIH295R | ATCC | Carcinoma | 2 |
| C71 | Central Nervous System | SNB19 | DMSZ | Glioblastoma | 2 |
| C71 | Central Nervous System | SKNAS | ATCC | neuroblastoma | 2 |
| C71 | Central Nervous System | H4 | ATCC | Glioblastoma | 2 |
| C71 | Central Nervous System | D283Med | ATCC | Medulloblastoma | 2 |
| C71 | Brain | A172 | ATCC | Brain Glioblastoma | 2 |
| C71 | Central Nervous System | CCFSTTG1 | ATCC | Astrocytoma | 2 |
| C71 | Central Nervous System | SKNFI | ATCC | neuroblastoma | 2 |
| C71 | Central Nervous System | DBTRG05MG | ATCC | Glioblastoma | 2 |
| C71 | Central Nervous System | SW1088 | ATCC | Glioblastoma | 2 |
| C72 | Brain | BE2C | ATCC | neuroblastoma | 2 |
| C72 | Brain | CHP212 | ATCC | neuroblastoma | 2 |
| C72 | Brain | SKNDZ | ATCC | neuroblastoma | 2 |
| C73 | Thyroid gland | TT | ATCC | Carcinoma | 2 |
| C73 | Thyroid gland | CAL62 | DSMZ | Carcinoma | 2 |
| C73 | Thyroid gland | CGTHW1 | DSMZ | Carcinoma | 2 |
| C73 | Thyroid gland | BHT101 | DSMZ | Carcinoma | 2 |
OrganismHomo sapiens
ClinicalinformationC40,
C71,
C50,
C20,
C53,
C42,
C61,
C15,
C64,
C49,
C22,
C18,
C06,
C51,
C13,
... 12 other values
OrganismpartOvary,
lung,
muscle,
Central Nervous System,
Stomach,
Pharynx,
Uterus,
Vulva,
prostate,
Hematopoietic and Lymphatic System,
kidney,
Pancreas,
Connective and Soft Tissue,
Brain,
Skin,
... 14 other values
CelllineSW1417,
HOS,
L428,
NCIH295R,
AsPC1,
Caov4,
NCIH526,
JVM3,
A673,
SW982,
RPMI8226,
SNU1,
OE33,
REC1,
Capan2,
... 323 other values
BiosourceproviderDSMZ,
DMSZ,
ATCC,
ECACC
DiseasestateAcute Myeloid Leukemia,
Mesothelioma,
Liposarcoma,
Medulloblastoma,
Chronic Myelogenous Leukemia,
Myeloma,
Chronic Lymphocytic Leukemia,
Astrocytoma,
Acute T Cell Lymphoblastic Leukemia,
B-Cell Neoplasm,
Small Cell Carcinoma,
Melanoma,
Large Cell Lung Carcinoma,
Lung Adenocarcinoma,
Clear Cell Adenocarcinoma,
... 42 other values
Assays and Data
MIAME Score
Platforms-
Protocols-
Variables*
Processed-
Raw*